lojuxta 5mg capsules
amryt pharma - lomitapide - capsule - 5mg
lojuxta 10mg capsules
amryt pharma - lomitapide - capsule - 10mg
lojuxta 20mg capsules
amryt pharma - lomitapide - capsule - 20mg
lojuxta
amryt pharmaceuticals dac - lomitapide - hypercholesterolemia - lipid modifying agents - lojuxta is indicated as an adjunct to a low‑fat diet and other lipid‑lowering medicinal products with or without low-density-lipoprotein (ldl) apheresis in adult patients with homozygous familial hypercholesterolaemia (hofh). genetic confirmation of hofh should be obtained whenever possible. other forms of primary hyperlipoproteinaemia and secondary causes of hypercholesterolaemia (e.g. nephrotic syndrome, hypothyroidism) must be excluded.,
juxtapid capsule
chiesi farmaceutici s.p.a. - lomitapide (lomitapide mesylate) - capsule - 5mg - lomitapide (lomitapide mesylate) 5mg - miscellaneous antilipemic agents
juxtapid capsule
chiesi farmaceutici s.p.a. - lomitapide (lomitapide mesylate) - capsule - 10mg - lomitapide (lomitapide mesylate) 10mg - miscellaneous antilipemic agents
juxtapid capsule
chiesi farmaceutici s.p.a. - lomitapide (lomitapide mesylate) - capsule - 20mg - lomitapide (lomitapide mesylate) 20mg - miscellaneous antilipemic agents
lojuxta 10 mg
medison pharma ltd - lomitapide as mesylate - capsules - lomitapide as mesylate 10 mg - lomitapide - an adjunct to a low-fat diet and other lipid-lowering treatments, including ldl apheresis where available, to reduce low-density lipoprotein cholesterol (ldl-c), total cholesterol (tc), apolipoprotein b (apo b), and non-high-density lipoprotein cholesterol (non-hdl-c) in patients with homozygous familial hypercholesterolemia (hofh).
lojuxta 20 mg
medison pharma ltd - lomitapide as mesylate - capsules - lomitapide as mesylate 20 mg - lomitapide - an adjunct to a low-fat diet and other lipid-lowering treatments, including ldl apheresis where available, to reduce low-density lipoprotein cholesterol (ldl-c), total cholesterol (tc), apolipoprotein b (apo b), and non-high-density lipoprotein cholesterol (non-hdl-c) in patients with homozygous familial hypercholesterolemia (hofh).
lojuxta 5 mg
medison pharma ltd - lomitapide as mesylate - capsules - lomitapide as mesylate 5 mg - lomitapide - an adjunct to a low-fat diet and other lipid-lowering treatments, including ldl apheresis where available, to reduce low-density lipoprotein cholesterol (ldl-c), total cholesterol (tc), apolipoprotein b (apo b), and non-high-density lipoprotein cholesterol (non-hdl-c) in patients with homozygous familial hypercholesterolemia (hofh).